HK1044763A1 - Thienopyranecarboxamide derivatives - Google Patents

Thienopyranecarboxamide derivatives

Info

Publication number
HK1044763A1
HK1044763A1 HK02105973A HK02105973A HK1044763A1 HK 1044763 A1 HK1044763 A1 HK 1044763A1 HK 02105973 A HK02105973 A HK 02105973A HK 02105973 A HK02105973 A HK 02105973A HK 1044763 A1 HK1044763 A1 HK 1044763A1
Authority
HK
Hong Kong
Prior art keywords
compounds
treatment
urinary tract
lower urinary
polyfluoroalkoxy
Prior art date
Application number
HK02105973A
Other languages
English (en)
Inventor
Amedeo Leonardi
Gianni Motta
Carlo Riva
Rodolfo Testa
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of HK1044763A1 publication Critical patent/HK1044763A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
HK02105973A 1999-07-30 2002-08-15 Thienopyranecarboxamide derivatives HK1044763A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001704A IT1313581B1 (it) 1999-07-30 1999-07-30 Derivati tienopirancarbossamidici.
PCT/EP2000/007306 WO2001009140A1 (en) 1999-07-30 2000-07-28 Thienopyranecarboxamide derivatives

Publications (1)

Publication Number Publication Date
HK1044763A1 true HK1044763A1 (en) 2002-11-01

Family

ID=11383457

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105973A HK1044763A1 (en) 1999-07-30 2002-08-15 Thienopyranecarboxamide derivatives

Country Status (23)

Country Link
EP (1) EP1200445B1 (zh)
JP (1) JP2003506379A (zh)
KR (1) KR100705179B1 (zh)
CN (1) CN1155602C (zh)
AT (1) ATE250068T1 (zh)
AU (1) AU759085B2 (zh)
BR (1) BR0012871A (zh)
CA (1) CA2378302A1 (zh)
DE (1) DE60005368T2 (zh)
DK (1) DK1200445T3 (zh)
ES (1) ES2206296T3 (zh)
HK (1) HK1044763A1 (zh)
HU (1) HUP0202106A3 (zh)
IL (2) IL147441A0 (zh)
IT (1) IT1313581B1 (zh)
MX (1) MXPA02000820A (zh)
NO (1) NO20020476L (zh)
PL (1) PL198700B1 (zh)
PT (1) PT1200445E (zh)
RU (1) RU2225409C2 (zh)
TW (1) TWI239958B (zh)
WO (1) WO2001009140A1 (zh)
ZA (1) ZA200200687B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30111A1 (es) * 2006-02-03 2007-04-30 Recordati Ireland Ltd Sales de adicion de acido de n-(3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifluormetil-7h-tieno (3,2-b) piran-3-carboxamida
WO2009094560A2 (en) * 2008-01-24 2009-07-30 Semafore Pharmaceuticals, Inc. Thienopyranones as kinase inhibitors
CA2919776A1 (en) * 2013-08-08 2015-02-12 Galapagos Nv Thieno[2,3-c]pyrans as cftr modulators
US11760762B2 (en) * 2017-01-27 2023-09-19 Signalrx Pharmaceuticals, Inc. Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG65570A1 (en) * 1992-02-25 1999-06-22 Recordati Chem Pharm Heterobicyclic compounds
WO1999006382A1 (en) * 1997-08-01 1999-02-11 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
IT1293807B1 (it) * 1997-08-01 1999-03-10 Recordati Chem Pharm Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico

Also Published As

Publication number Publication date
NO20020476D0 (no) 2002-01-29
AU6988200A (en) 2001-02-19
AU759085B2 (en) 2003-04-03
ITMI991704A1 (it) 2001-01-30
ITMI991704A0 (it) 1999-07-30
KR20020022785A (ko) 2002-03-27
IT1313581B1 (it) 2002-09-09
KR100705179B1 (ko) 2007-04-06
IL147441A (en) 2007-06-03
CN1365363A (zh) 2002-08-21
NO20020476L (no) 2002-01-29
DE60005368T2 (de) 2004-07-01
RU2225409C2 (ru) 2004-03-10
PL198700B1 (pl) 2008-07-31
EP1200445A1 (en) 2002-05-02
ZA200200687B (en) 2002-10-30
JP2003506379A (ja) 2003-02-18
ES2206296T3 (es) 2004-05-16
DE60005368D1 (en) 2003-10-23
WO2001009140A1 (en) 2001-02-08
HUP0202106A2 (en) 2002-10-28
IL147441A0 (en) 2002-08-14
PT1200445E (pt) 2004-02-27
PL363115A1 (en) 2004-11-15
DK1200445T3 (da) 2004-01-12
HUP0202106A3 (en) 2004-12-28
TWI239958B (en) 2005-09-21
BR0012871A (pt) 2002-04-16
MXPA02000820A (es) 2004-03-19
CA2378302A1 (en) 2001-02-08
EP1200445B1 (en) 2003-09-17
ATE250068T1 (de) 2003-10-15
CN1155602C (zh) 2004-06-30

Similar Documents

Publication Publication Date Title
MX9703518A (es) Dihidropirimidinas y usos de las mismas.
JO2503B1 (en) Benzathiazole derivatives
WO1998051311A3 (en) Dihydropyrimidines and uses thereof
MY122826A (en) Dipeptide nitrile cathepsin k inhibitors
AU2003282233A1 (en) Quinoline derivatives as glucokinase ligands
MXPA02001667A (es) Composicion y metodo neuroterapeutico.
TR200103095T2 (tr) Renin engelleyiciler.
ATE370138T1 (de) Neue imidazopyridine und ihre verwendung
WO2001094345A3 (en) Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
MY120400A (en) Isoxazolecarboxamide derivatives
CA2402991A1 (en) Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
GB0100620D0 (en) Chemical cokpounds V
CA2380414A1 (en) Method of cancer treatment
PL1697394T3 (pl) Inhibitory COMT
DE60005368D1 (en) Thienopyran-carboxamid-derivate
CA2378834A1 (en) Pyrazinones, compositions containing such compounds
PL369819A1 (en) Pyrimidine derivatives
MY133785A (en) Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
HUP0100102A2 (hu) Fenil-amino-alkilkarbonsav-származékok és fenil-amino-alkilkarbonsav-származékokat tartalmazó gyógyszerészeti készítmények
NO20004405L (no) Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati
NO994903L (no) Behandling eller profylakse av prostatakreft og benign prostatahyperplasi med selektive östrogenreseptormodulatorer
WO2001000196A3 (en) Mirtazapine for weight gain in wasting diseases
HK1083197A1 (en) A pharmaceutical formulation and its use in the treatment of inner ear diseases
ATE297926T1 (de) Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen
EP1172360A4 (en) NEUROTROPHIN POTENTIALIZERS

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080728